Previous 10 | Next 10 |
Gainers: Sonoma Pharmaceuticals (SNOA) +29%. Blue Water Vaccines (BWV) +32%. XORTX Therapeutics (XRTX) +27%. Eqonex (EQOS) +21%. TETRA Technologies (TTI) +20%. Enovix (ENVX) +18%. JAKKS Pacific (JAKK) +18%. Blue Apron Holdings (APRN) +17%. Borr Drilling (BORR) +16%. Western Digital Corp...
Gainers: Sonoma Pharmaceuticals (SNOA) +42%. XORTX Therapeutics (XRTX) +18%. Retractable Technologies (RVP) +14%. Catalent (CTLT) +12%. Field Trip Health (FTRP) +5%. Losers: Spero Therapeutics (SPRO) -61%. Semler Scientific (SMLR) -23%. Galmed Pharmaceu...
What to Know About Buying Penny Stocks on May 3rd, 2022 After an interesting start to May for penny stocks and blue chips, there is a lot for investors to know right now. While morning gainers like Forte Biosciences Inc. ( NASDAQ: FBRX ) and SoundHound AI Inc. ( NASDAQ: SOUN ) a...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s time for another dive into the biggest pre-market stock movers as we prepare for a busy day of trading on Tuesday! Source: oneinchpunch/Shutterstock.com Approval from the EPA and FCC, earnings reports, a...
Sonoma Pharmaceuticals (NASDAQ:SNOA) and its partner MicroSafe Group DMCC said they received U.S. Environmental Protection Agency (EPA) approval for Nanocyn as a hospital-grade disinfectant in the U.S. Nanocyn, which is manufactured by Sonoma using its patented Microcyn technology, is a ...
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions a...
Gainers: Adagio Therapeutics (ADGI) +48%. Vyant Bio (VYNT) +23%. Vir Biotechnology (VIR) +19%. Sonoma Pharmaceuticals (SNOA) +15%. Syros Pharmaceuticals (SYRS) +15%. Losers: Revelation Biosciences (REVB) -40%. UpHealth (UPH) -29%. The Valens (VLNS)...
Sonoma Pharma (NASDAQ:SNOA) is trading ~22% higher after it launched its urinary tract infection catheter and bladder rinse product in New Zealand, Australia and South Africa. The product, Microdox, is a non-irritating and non-toxic solution a...
Adagio Therapeutics (ADGI) +64% as COVID drug ADG20 meets main goals in trial; EUA filing in Q2. Vyant Bio (VYNT) +29% on FY results. Sonoma Pharmaceuticals (SNOA) +24% launches new urinary tract infection product through distributors in New Zealand, Australia and Sou...
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, and dermatological conditio...
News, Short Squeeze, Breakout and More Instantly...
Sonoma Pharmaceuticals Inc. Company Name:
SNOA Stock Symbol:
NASDAQ Market:
Sonoma Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...
BOULDER, CO / ACCESSWIRE / July 9, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and ...